NSE:TATAINVEST 1 October 2025

April 30, 2026, 3:57 AM EDT. Park Medi World shares fell 0.52% to ₹234 on the NSE after early gains on April 30, despite a robust 56% year-to-date return. The healthcare company's stock initially rallied following a 'buy' rating from Choice Institutional Equities, which set a ₹320 target price, citing expected compound annual growth rates (CAGR) of 26.3% revenue, 27.1% EBITDA, and 34.6% PAT through 2026-2029. The broker highlighted growth drivers including capacity expansion, improved case mix, and payor mix optimization. Park recently opened a multispecialty hospital in Panchkula, expanding its Northern India presence alongside ongoing developments in Mohali. The group operates 16 hospitals with nearly 4,000 beds, targeting 5,460 beds by 2028. The stock's resilience contrasts broader market weakness, gaining 2.39% weekly and 23.28% monthly, reflecting investor confidence in its expansion and operational strategy.